CASC2 and cervical carcinoma: In addition, CASC2 can competitively bind to miR-21 and upregulate the expression of PTEN, the downstream target protein of miR-21, thereby promoting the chemosensitivity of cervical cancer cells to cisplatin and inhibiting the development of cervical cancer [32].